genomiQa is has grown out of a collaboration between our founders Dr Nic Waddell and Prof. John Pearson of QIMR Berghofer Medical Research Institute in Brisbane, Australia.
genomiQa is working with pharma and biotech companies to implement whole genome into clinical development and with health systems to integrate whole genome analysis for cancer (CapeDx) and germline (GulfDx).
genomiQa is seeking venture investment to expand our international reach. Contact Us for more information on our plans.
Dr Nic Waddell is a leader in interpreting whole genome next generation sequence data, with multiple Nature publications. Her ongoing research focuses on identifying mutational processes and therapeutic opportunity in a variety of cancer types. She works toward her goal to see quality genomics implemented into clinical settings.
John has created software for medical researchers and has developed analysis pipelines for whole genome, exome and panel sequencing. He has worked with next-generation sequencing projects in the USA and Australia, and has been involved in the 1000 Genomes Project and the International Cancer Genome Consortium (ICGC).
Anthony has experience in developing global relationships to facilitate technology commercialisation. He has a background in both the commercial and operational elements of pharmaceutical development in both global companies and start-ups.
Dr Georgina Hollway is an experienced genome analyst in both clinical and research environments, having worked at several of Australia’s leading Medical Research Institutes. Her achievements include a first author Nature paper and Eureka Prize for Haematopoietic Stem Cell research.